Free Republic

A retracted study on hydroxychloroquine and news that the coronavirus may be mutating drew reactions Friday night from Fox News medical contributor Dr. Marc Siegel. "So Lancet, with egg on its face, a renowned journal, is suddenly withdrawing this study," Siegel noted during an appearance on "Tucker Carlson Tonight" A database by Surgisphere Corp. of Chicago was used in an observational study of nearly 100,000 patients that appeared May 22 in The Lancet, an influential medical journal. The study tied the malaria drugs hydroxychloroquine and chloroquine to a higher risk of death in hospitalized patients with the virus. The validity...

First, the highly respected Lancet medical journal retracted a major study about hydroxychloroquine. And now, the esteemed New England Journal of Medicine has yanked another study, this one concerning COVID-19 and blood pressure drugs. Both studies relied on data supplied by a U.S. analytics company called Surgisphere. “A Guardian investigation can reveal the US-based company Surgisphere, whose handful of employees appear to include a science fiction writer and an adult-content model, has provided data for multiple studies on Covid-19 co-authored by its chief executive, but has so far failed to adequately explain its data or methodology,” The Guardian reported. "A...

The Lancet is one of the oldest and most respected medical journals in the world. Recently, they published an article on Covid patients receiving hydroxychloroquine with a dire conclusion: the drug increases heartbeat irregularities and decreases hospital survival rates. This result was treated as authoritative, and major drug trials were immediately halted – because why treat anyone with an unsafe drug? Now, that Lancet study has been retracted, withdrawn from the literature entirely, at the request of three of its authors who “can no longer vouch for the veracity of the primary data sources”. Given the seriousness of the topic...

The authors 'can no longer vouch for the veracity of the primary data sources' A major medical magazine has retracted a study it published that claimed to have found increased mortality in coronavirus patients who took the drug hydroxychloroquine. The Lancet issued the retraction Thursday afternoon after successive days of questions regarding the study and the data underpinning it, both of which came from the medical analytics company Surgisphere. That study, published on May 22, determined that hydroxychloroquine – a drug repeatedly touted by President Trump as a possible viable treatment for the coronavirus – was "associated with an increased...

The Lancet, a peer-reviewed medical journal that published a 96,000-subject study indicting the efficacy of the politically controversial hydroxychloroquine for COVID-19 has retracted its findings that the malaria medication led to an increased risk of death.

Weeks ago a study claiming that the antimalarial drug hydroxychloroquine was linked to higher rates of mortality with coronavirus patients was based on possibly bogus data from a small America-based company called Surgisphere, reports The Guardian. The World Health Organization and many national governments changed their policies and treatment guidelines based on this faulty study. Many in the media freaked out when Trump revealed he was taking the drug to protect him from the coronavirus. A Guardian investigation can reveal the US-based company Surgisphere, whose handful of employees appear to include a science fiction writer and an adult-content model, has...

The Lancet has issued an "expression of concern" over a large-scale study of hydroxychloroquine and chloroquine it published that led to the World Health Organization suspending clinical trials of the anti-viral drugs as a potential treatment for COVID-19. In a statement, the medical journal acknowledged "important" questions over the research, after dozens of scientists issued an open letter last week raising concerns about its methodology and transparency around the data, which was provided by the firm Surgisphere. "Although an independent audit of the provenance and validity of the data has been commissioned by the authors not affiliated with Surgisphere and...

On its face, it was a major finding: Antimalarial drugs touted by the White House as possible COVID-19 treatments looked to be not just ineffective, but downright deadly. A study published on 22 May in The Lancet used hospital records procured by a little-known data analytics company called Surgisphere to conclude that coronavirus patients taking chloroquine or hydroxychloroquine were more likely to show an irregular heart rhythm—a known side effect thought to be rare—and were more likely to die in the hospital. Within days, some large randomized trials of the drugs—the type that might prove or disprove the retrospective study’s...

Medical journal The Lancet on May 29 issued a correction to a recent study which found that antimalarial drugs Hydroxychloroquine and chloroquine were linked with an increased risk of mortality in hospitals, and an increased frequency of irregular heart rhythms. The study, titled, “Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis,” and published on May 22, included records of 96,032 patients from 671 hospitals in six continents. The patients were hospitalized between Dec. 20, 2019, and April 14, 2020. Patients receiving the anti-malarials were put in four different groups: chloroquine alone, chloroquine...

The left-wing Lancet journal has declared that sexual and reproductive health services must be considered essential and given central attention in the response to COVID-19. “A sexual and reproductive health and justice policy agenda must be at the heart of the COVID-19 response,” states an article this week in the once prestigious journal. “A sexual and reproductive health and justice framework — one that centres human rights, acknowledges intersecting injustices, recognises power structures, and unites across identities — is essential for monitoring and addressing the inequitable gender, health, and social effects of COVID-19,” it asserts. (snip) For the Lancet, pro-life...

The once prestigious Lancet medical journal has published a bizarre book review asserting that “white Americans continue to mobilise to maintain or extend the exclusive advantages whiteness offers those who can become white.” The Lancet selected Rhea W. Boyd, a Minority Health Policy Fellow at Harvard’s School of Public Health, to review a 2019 book called Dying of Whiteness by Jonathan Metzl, whose thesis is that “right-wing backlash policies have mortal consequences — even for the white voters they promise to help.” In his book, Metzl argues that white mortality is up in the United States ever since the 2016...

"Scientists have raised questions about the dataset published in The Lancet last week that triggered the suspension of clinical trials around the world—and about Surgisphere Corporation, the company behind the study. " Surgisphere Corporation, the company that supplied data for a controversial study on the health risks of hydroxychloroquine for COVID-19 patients published in The Lancet last week (May 22), has found itself in the spotlight after researchers raised questions about the dataset. The Lancet study, which lists Surgisphere founder and CEO Sapan Desai as one of four coauthors, reported harmful effects tied to the anti-malaria drug hydroxychloroquine among patients...

The use of Real World Evidence in Covid-19 is growing, and that’s a good thing. Properly implemented, RWE has the potential to deliver solid results faster than Randomized Controlled Trials, as I explained in a .css-mckguv{-webkit-transition:background 0.25s var(--ease-in-out-quad),color 0.25s var(--ease-in-out-quad);transition:background 0.25s var(--ease-in-out-quad),color 0.25s var(--ease-in-out-quad);color:var(--theme-ui-colors-accent,#6166DC);}.css-mckguv:visited{color:var(--theme-ui-colors-accent,#6166DC);opacity:0.85;}.css-mckguv:hover,.css-mckguv:focus{-webkit-text-decoration:underline;text-decoration:underline;}previous blog post.So I couldn’t miss the largest observational study published to date on the effects of (hydroxy-)chloroquine, in 96 032 hospitalised Covid-19 patients, from an international registry comprising 671 hospitals in six continents:Mehra, M. R., Desai, S. S., Ruschitzka, F., & Patel, A. N. (2020). ‘Hydroxychloroquine or chloroquine with or without a macrolide for treatment of...

Paris (AFP) - Dozens of scientists have raised concerns over a large-scale study of hydroxychloroquine and chloroquine published in the Lancet that led to the World Health Organization suspending clinical trials of the anti-viral drugs as a potential treatment for COVID-19. Hydroxychloroquine, normally used to treat arthritis, has become one of the most high profile drugs being tested for use against the new coronavirus. This is partly because of comments by public figures including US President Donald Trump, who announced this month he was taking the drug as a preventative measure. In research published in the Lancet on May 22,...

NOTE: THIS ARTICLE HAS BEEN TRANSLATED USING GOOGLE TRANSLATE FROM FRENCH Jacques Reynes, head of the infectious diseases department at the Montpellier University Hospital, participated in studies on hydroxychloroquine: via the European Discovery and Covidoc trials, specific to Occitania. Treatment stop, Raoult controversy ... he regrets a "runaway" which will undoubtedly not allow to have indisputable data on the effectiveness of the treatment. Q: What do you think of this very critical Lancet study on the interest of hydroxychloroquine, and the cascading effects of the publication of this prestigious scientific journal published last Friday, until the ban on the use...

The Spanish health watchdog has said it sees no reason to stop the use of hydroxychloroquine (HCQ), the potentially dangerous medicine touted as a Covid-19 treatment by the US president. Several European nations, including France, Italy and Belgium, have decided to suspend prescription of the anti-malaria drug, which came to international prominence after US President Donald Trump said the medicine could be used to tackle Covid-19 and that he himself was taking it. The Spanish health watchdog, AEMPS, said the paper published by the magazine Lancet, which warned about health risks associated with HCQ, was not conclusive enough to stop...

Questions have been raised by Australian infectious disease researchers about a study published in the Lancet which prompted the World Health Organization to halt global trials of the drug hydroxychloroquine to treat Covid-19. The study published on Friday found Covid-19 patients who received the malaria drug were dying at higher rates and experiencing more heart-related complications than other virus patients. The large observational study analysed data from nearly 15,000 patients with Covid-19 who received the drug alone or in combination with antibiotics, comparing this data with 81,000 controls who did not receive the drug. The findings prompted researchers from around...

Researchers at Australian National University (ANU) have called for ‘climate change’ to be recorded as a cause of death on death certificates. They claim that in Australia, the rate of people dying as a result of global warming may be 50 times higher than is officially acknowledged. In a letter to The Lancet Planetary Health, researchers Arnagretta Hunter and Simon Quilty claim the impact of climate change is currently understated. “Climate change is the single greatest health threat that we face globally even after we recover from coronavirus. “We are successfully tracking deaths from coronavirus, but we also need healthcare...

Sen. Tom Cotton, R-Ark. stood by his earlier suggestion that the deadly coronavirus may have originated in a high-security biochemical lab in Wuhan, China, telling "The Story" Tuesday that we "need to be open to all possibilities" in exploring the origins of the outbreak that has sickened more than 75,000 people around the world. When host Martha MacCallum pressed the Senator on his startling and unverified claim, Cotton cited a study published by Chinese scientists in The Lancet, which he called a "respected international science journal." "I'm suggesting we need to be open to all possibilities and we need to...

Fighting the new coronavirus has been a battle against the unknown for doctors. ... Now, an account by medics on the front line of this epidemic, at the Jinyintan Hospital, in Wuhan, is starting to provide answers. A detailed analysis of the first 99 patients treated there has been published in the Lancet medical journal. Lung assault All of the 99 patients taken to the hospital had pneumonia - their lungs were inflamed and the tiny sacs where oxygen moves from the air to the blood were filling with water. Other symptoms were: 82 had fever 81 had a cough...